Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study.

Luca D'OnofrioSilvia PieraliceErnesto MaddaloniCarmen MignognaSara SterpettiLucia CoraggioCecilia LuordiGloria GuariscoGaetano LetoFrida LeonettiSilvia ManfriniRaffaella Buzzetti

Published in: Diabetes, obesity & metabolism (2021)

The COVID-19 lockdown did not significantly impact glycaemic control in people with T2D. People with poor psychological well-being may experience a worsening a glycaemic control because of restrictions resulting from lockdown. These findings may aid healthcare providers in diabetes management once the second wave of COVID-19 has ended.

Keyphrases

coronavirus disease
type diabetes
sars cov
healthcare
cardiovascular disease
respiratory syndrome coronavirus
adipose tissue
insulin resistance
health insurance
affordable care act